Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
RSC Medicinal Chemistry is Scopus-indexed (Q2, CiteScore 5.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Royal Society of Chemistry.
Checked against the index lists dated .
ISSN 2632-8682Verify ISSN ↗
Publisher: Royal Society of Chemistry
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 63 / 191 | 67th | Q2 |
| Organic Chemistry | 74 / 215 | 65th | Q2 |
| Pharmacology | 116 / 328 | 64th | Q2 |
| Drug Discovery | 65 / 161 | 59th | Q2 |
| Biochemistry | 189 / 448 | 57th | Q2 |
| Molecular Medicine | 90 / 179 | 50th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q2, CiteScore 5.7.
RSC Medicinal Chemistry is Q2 in Pharmaceutical Science (rank 63 of 191), Q2 in Organic Chemistry (rank 74 of 215) and Q2 in Pharmacology (rank 116 of 328), by CiteScore 2025. It is ranked in 6 subject areas in all.
RSC Medicinal Chemistry is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.7, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.756, quartile Q1, with an H-index of 87.
RSC Medicinal Chemistry is published by Royal Society of Chemistry. Its ISSN is 2632-8682.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
RSC Medicinal Chemistry has an h-index of 53 and a 2-year mean of 4.54 citations per paper (OpenAlex). Its Scopus CiteScore is 5.7, quartile Q2. On 2-year citations it ranks #36 of 177 Scopus journals in Pharmaceutical Science.
RSC Medicinal Chemistry published 425 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (31.3%), India (16.2%) and United States (9.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.